MedTrace Logo

Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy

NCT06784479 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2026-02-24

No results posted yet for this study

Summary

This study helps patients find the optimal sedation regimen in drug-induced sleep endoscopy

Conditions

  • Sedative Effect During Drug-induced Sleep Endoscopy
  • Obstructive Sleep Apnea (OSA)

Interventions

DRUG

Remimazolam and Propofol

Application of Remimazolam and Propofol to induce sleep

DRUG

Propofol

Application of Propofol to induce sleep

DRUG

Midazolam and propofol

Application of Midazolam and Propofol to induce sleep

Sponsors & Collaborators

  • Dan Liu

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-03-01
Completion
2026-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06784479 on ClinicalTrials.gov